About NuCare Laboratories
NuCare Laboratories is a company based in Mehsana (India) founded in 1985. It operates as a B2B. NuCare Laboratories offers products and services including Pharmaceutical Products and Contract Manufacturing Services. NuCare Laboratories operates in a competitive market with competitors including Unither, Akums, Jubilant Life Sciences, Recipharm and CoreRx, among others.
- Headquarter Mehsana, India
- SectorsHealthcare
- Email••••••••
- Phone•••• ••••
- Website nucarelabs.com
- Social Facebook
- Legal Name Nucare Labs Llp
- Date of Incorporation 30 Sep, 2016
- Jurisdiction Mehsana, Gujarat, India
- Annual Revenue₹15.24 Cr
FY 2023 · +152% YoY
- Net Profit₹43.6 Lakh
FY 2023 · 3% margin
- EBITDA₹85.4 Lakh
FY 2023 · 6% margin
Associated legal entities of NuCare Laboratories
NuCare Laboratories operates through Nucare Labs Llp (active). Its filings, financials, charges and directors are on the company page.
| Legal entity | Status | Incorporated | Registered in | Revenue (FY 2023) | Employees | Directors | Company page |
|---|---|---|---|---|---|---|---|
| Nucare Labs Llp CIN AAH-5212 | Active | 30 Sep 2016 | Mehsana, Gujarat | ₹15.2 Cr | – | 2 | View details |
Products & Services of NuCare Laboratories
NuCare Laboratories offers a comprehensive portfolio of products and services, including Pharmaceutical Products and Contract Manufacturing Services.
Wide range of medicines for health and wellness through contract services.
Production of pharmaceuticals for partner companies globally.
Board of directors of Nucare Labs Llp (NuCare Laboratories)
Nucare Labs Llp is the primary company behind NuCare Laboratories. The board of Nucare Labs Llp currently have 2 directors; the longest-serving is Jagdishbhai Ambalal Patel, appointed in 2016.
| Director | Designation | Appointed | Tenure | Entity |
|---|---|---|---|---|
| Jagdishbhai Ambalal Patel DIN 07610322 | Designated Partner | 30 Sep 2016 | 10 yrs | Nucare Labs Llp |
| Ronak Jagdishbhai Patel DIN 07610935 | Designated Partner | 30 Sep 2016 | 10 yrs | Nucare Labs Llp |
Financials of NuCare Laboratories
Figures of Nucare Labs Llp, the primary company behind NuCare Laboratories, for FY 2023. Revenue was ₹15.24 Cr (+152% year on year). Net profit was ₹43.6 Lakh (3% margin). EBITDA was ₹85.4 Lakh (6% margin). Revenue has grown at a compounded annual rate of +87% over three years.
- ₹15.24 CrRevenue · FY 2023 · +152% YoY
- ₹43.6 LakhNet profit · 3% margin
- ₹85.4 LakhEBITDA · 6% margin
- +87%Revenue CAGR, 3 years
Balance sheet, profit and loss, cash flow and ratios of Nucare Labs Llp are on its company page.
Detailed financial statements for NuCare Laboratories
Statement rows, ratios, five-year trends and downloadable financials of the group companies require an active premium plan.
- Statement rows
- Financial ratios
- Five-year trends
- Downloads
Verified entity values are shown only after access is granted.
Competitors of NuCare Laboratories
NuCare Laboratories operates in a dynamic and competitive business environment, facing competition from various established players and emerging companies in the market. The competitive landscape includes prominent companies such as Unither, Akums, Jubilant Life Sciences, Recipharm and CoreRx, among others.
| Company Name | Domain | Founded | HQ Location | Total funding | Employees | Description |
|---|---|---|---|---|---|---|
| unither-pharma.com | 1993 | Paris, France | – | – | Contract development and manufacturing organization for proprietary and generic drugs | |
| akums.in | 2004 | Delhi, India | $70M | 395 | CDMO focusing on spectrum of dosage forms and therapeutic segments | |
| jubl.com | 1978 | Noida, India | – | – | Company offering a suite of R&D and manufacturing services for small molecules and generics | |
| recipharm.com | 1995 | Jordbro, Sweden | – | 1,083 | Pharmaceutical development and manufacturing services are offered contractually. | |
| corerxpharma.com | 2006 | Clearwater, United States | $15M | – | CDMO with a focus on early phase drug product development | |
| neclife.com | 1995 | Chandigarh, India | $46.85M | 175 | Cephalosporin APIs and generic formulations are manufactured. | |
| windlas.com | 2001 | Gurugram, India | $12.96M | 1,264 | Biopharma regulatory affairs, quality control, and strategy services are provided. | |
| medpharm.com | 1998 | Guildford, United Kingdom | – | 108 | Topical and inhaled drug delivery formulations are developed and manufactured. |
Detailed competitors of NuCare Laboratories
The full competitor set, operating metrics and side-by-side benchmarks require an active premium plan.
- Full competitor set
- Operating metrics
- Benchmarks
- Competitive positioning
Verified entity values are shown only after access is granted.
Similar companies to NuCare Laboratories
10 companies that operate in the same segment as NuCare Laboratories (Pharmaceuticals & Distribution), ranked by their profile score on The Company Check.
| Company | Description | Founded | Location | Total funding | Revenue | Employees |
|---|---|---|---|---|---|---|
Pharmaceutical products are manufactured and marketed worldwide. | 1891 | Kenilworth, Warwickshire, United Kingdom | – | USD 64.93 B | 781 | |
Therapeutics for neurology, oncology, rare, and endocrinology diseases are developed. | 2014 | New York, New York, United States | USD 1.3 B | USD 8.26 M | 750 | |
Developer of pharmaceutical products for treating multiple diseases | 1980 | Thousand Oaks, California, United States | – | USD 33.23 B | 28,000 | |
Biopharmaceutical research and drug development are conducted globally by AbbVie. | 2012 | Chicago, Illinois, United States | – | USD 61.16 B | 55,000 | |
Traditional pharmaceutical medicines are developed for multiple health fields. | 1876 | United States | – | USD 65.18 B | 47,000 | |
Developer of medicines to treat HIV/AIDS, liver diseases, cancer & others | 1987 | Foster City, California, United States | – | USD 29.45 B | 17,600 | |
Novel therapeutics are discovered using an AI-enabled drug platform. | 2013 | New York, New York, United States | USD 456.66 M | USD 74.68 M | – | |
Treatments for anemia and fibrosis by exploiting connective tissue growth factor (CTGF) and hypoxia-inducible factor (HIF) biology. | 1993 | San Francisco, California, United States | USD 215.5 M | USD 29.62 M | 225 | |
Developer of medical devices, generic pharmaceuticals, and nutrition products | 1888 | Libertyville, Illinois, United States | – | USD 44.33 B | 3,710 | |
Medicines and health products are retailed through pharmacy outlets. | 2006 | Hyderabad, Telangana, India | USD 268.78 M | USD 734.57 M | 25,010 |
Unlock complete access to The Company Check
Get unrestricted viewing across everything we track — from companies and brands to investors, funding rounds, acquisitions, financials, and more.
- Unlimited viewing on all profiles Companies, investors, financials, funding, acquisitions & directors
- Full access to every database India & global coverage, advanced filters and rich profile details
- Always-on access from your team account Single premium plan for everything you see on the portal
Frequently Asked Questions about NuCare Laboratories
NuCare Laboratories was founded in 1985.
NuCare Laboratories is headquartered in Mehsana, India. It is registered at Mehsana, Gujarat, India.
The primary company behind NuCare Laboratories, Nucare Labs Llp, reported revenue of ₹15.24 Cr for FY 2023, up 152% year on year.
NuCare Laboratories (India) has been involved in manufacturing and supplying a wide range of pharmaceutical products since 1985. They offer contract manufacturing for leading companies and export to global markets. Based in Mehsana, Gujarat, India, they maintain state-of-the-art infrastructure and adhere to strict quality controls. Their extensive network ensures efficient distribution and client satisfaction in healthcare.
NuCare Laboratories's top competitors include Jubilant Life Sciences, Akums and Nectar Lifesciences.
NuCare Laboratories offers Pharmaceutical Products and Contract Manufacturing Services.
NuCare Laboratories operates through Nucare Labs Llp.
The legal entities of NuCare Laboratories currently have 2 directors, including Jagdishbhai Ambalal Patel, Ronak Jagdishbhai Patel.